To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)
Clinical trial NCT06698484 · RECRUITING
Trial details
- NCT number
- NCT06698484
- Sponsor
- National University of Malaysia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2025-06-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.